Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Marketing in rare diseases – getting closer to your customers

January 20, 2010 Sales and Marketing Orphan, marketing, marketing ideas, niche

The 21st century healthcare industry is reorientating its strategic focus on the increasingly successful areas of orphan and rare diseases. …
Feature

Triple approval for Novartis in Japan

January 20, 2010 Sales and Marketing Afinitor, Asia, Exforge, Galvus, Japan, Novartis, hypertension

Japanese regulators have approved three new Novartis medicines for use patients with type II diabetes, high blood pressure and advanced …
News

Obama presses on in spite of public doubts

January 20, 2010 Sales and Marketing Obama, US healthcare

President Obama is making slow but steady progress towards making his healthcare reforms a reality – but is also steadily …
News

Lundbeck and Teva launch Azilect in France

January 20, 2010 Sales and Marketing Azilect, France, Lundbeck, Teva

Lundbeck and Teva France have launched Azilect in France following the successful conclusion of pricing and reimbursement discussions with the …
News

FDA to study effects of medication during pregnancy

January 20, 2010 Research and Development, Sales and Marketing FDA, paediatric

A new US-based collaborative research programme to study the effects of medication on mothers and their babies has been launched. …
News

AstraZeneca continues personalised healthcare push

January 19, 2010 Sales and Marketing AstraZeneca, Dako, Diagnostics, Iressa

AstraZeneca and cancer diagnostics specialist Dako Denmark are to develop companion diagnostics for a number of the pharma company’s oncology …
News

Victoza pill trial begins

January 19, 2010 Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II

A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …
News

NICE approves Trabectedin

January 19, 2010 Sales and Marketing NICE, PharmaMar, Trabectedin, soft tissue sarcoma

Patients with advanced soft tissue sarcoma could now benefit from PharmaMar’s new drug trabectedin, after the NICE granted its approval. …
News

US generics company expands into Eastern Europe

January 19, 2010 Sales and Marketing Alvogen, Eastern Europe, generics

US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …
News

Avantium appoints Gunnar Staaf

January 19, 2010 Sales and Marketing appointment, sales and marketing

Amsterdam-based technology company Avantium has appointed Gunnar Staaf as chief executive of its pharma business in preparation for spinning it …
Appointment

Pharma responds to disaster in Haiti

January 18, 2010 Sales and Marketing Haiti, disaster, industry reputation, relief

A number of pharmaceutical companies have sprung into action to help the relief effort in Haiti. The island has been …
News

Commission probes Lundbeck on alleged generic blocking

January 18, 2010 Sales and Marketing European Commission, Lundbeck, generics, kroes

The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …
News

Cladribine still set to be first oral MS treatment

January 18, 2010 Sales and Marketing Cladribine, FTY-720, MS, Merck Serono

Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …
News

MSI launches Brand Services division

January 18, 2010 Sales and Marketing MSI

The MSI Consultancy has launched a new division to help the pharma industry maximise the impact of its brands. The …
News

Cephalon’s pharma chief to step down

January 18, 2010 Sales and Marketing Cephalon, appointment, sales and marketing

Cephalon’s executive vice president of worldwide pharmaceutical operations Robert Roche is leaving the company at the beginning of February to …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026